Rhett Alden

At Elsevier, Rhett is passionate about improving patient outcomes by merging the most trusted clinical content with the optimal technology. As the CTO of Health Markets business at Elsevier, he partners with the business to drive technical Product development with an inclusive and diverse global team to support of the Health Markets business. He has spent his entire career developing Clinical solutions and leading technology strategy in Healthcare and Life Sciences. Most recently, Rhett championed the development of disruptive offerings leveraging Generative AI for Elsevier in the Clinical and Health educations spaces. In addition, while at GEHC for over 15 years ago he drove the development of advanced diagnostic solutions in Oncology and Pathology and most recently prior to Elsevier developed FDA/EU regulated digital devices to assist patients in self-management of chronic diseases. At Elsevier, Rhett is passionate about improving patient outcomes by merging trusted clinical content with the optimal technology.